Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor

Joensuu, Heikki; Roberts‎, Peter; Sarlomo‐Rikala, Maarit; C. Andersson, Leif; Tervahartiala, Pekka; A. Tuveson, David; Silberman, Sandra; Capdeville, Renaud; Dimitrijević, Saša; Druker, Brian; D. Demetri, George

doi:10.1056/nejm200104053441404

Public

Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor

Published in New England Journal of Medicine • Apr 5, 2001

Authors:

Heikki Joensuu

Peter Roberts‎

Maarit Sarlomo‐Rikala

Abstract

Gastrointestinal stromal tumors are a group of mesenchymal neoplasms that arise from precursors of the connective-tissue cells of the gastrointestinal tract.1 They occur predominantly in middle-aged and older persons, and approximately 70 percent of the tumors are found in the stomach, 20 to 30 perc...

Subject

Medicine

Tyrosine-kinase inhibitor

Tyrosine kinase

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!